Annual Retained Earnings
-$115.63 M
+$333.80 K+0.29%
30 April 2024
Summary:
PharmaCyte Biotech annual retained earnings is currently -$115.63 million, with the most recent change of +$333.80 thousand (+0.29%) on 30 April 2024. During the last 3 years, it has fallen by -$8.22 million (-7.65%). PMCB annual retained earnings is now -18746.78% below its all-time high of -$613.50 thousand, reached on 30 April 2002.PMCB Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$92.20 M
+$23.42 M+20.26%
31 July 2024
Summary:
PharmaCyte Biotech quarterly retained earnings is currently -$92.20 million, with the most recent change of +$23.42 million (+20.26%) on 31 July 2024. Over the past year, it has increased by +$24.15 million (+20.75%). PMCB quarterly retained earnings is now -14232.92% below its all-time high of -$643.30 thousand, reached on 31 January 2003.PMCB Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.3% | +20.8% |
| 3 y3 years | -7.7% | +15.7% |
| 5 y5 years | -15.6% | +9.8% |
PMCB Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -7.7% | +0.3% | at high | +22.8% |
| 5 y | 5 years | -15.6% | +0.3% | at high | +22.8% |
| alltime | all time | <-9999.0% | +0.3% | <-9999.0% | +22.8% |
PharmaCyte Biotech Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | - | -$92.20 M(-20.3%) |
| Apr 2024 | -$115.63 M(-0.3%) | -$115.63 M(-1.2%) |
| Jan 2024 | - | -$116.97 M(+0.5%) |
| Oct 2023 | - | -$116.35 M(-2.6%) |
| July 2023 | - | -$119.46 M(+3.0%) |
| Apr 2023 | -$115.96 M(+3.9%) | -$115.96 M(+0.1%) |
| Jan 2023 | - | -$115.84 M(+0.7%) |
| Oct 2022 | - | -$115.07 M(+1.7%) |
| July 2022 | - | -$113.19 M(+1.4%) |
| Apr 2022 | -$111.65 M(+3.9%) | -$111.65 M(+1.3%) |
| Jan 2022 | - | -$110.23 M(+0.7%) |
| Oct 2021 | - | -$109.41 M(+0.9%) |
| July 2021 | - | -$108.43 M(+1.0%) |
| Apr 2021 | -$107.41 M(+3.4%) | -$107.41 M(+0.9%) |
| Jan 2021 | - | -$106.45 M(+0.7%) |
| Oct 2020 | - | -$105.69 M(+0.9%) |
| July 2020 | - | -$104.74 M(+0.9%) |
| Apr 2020 | -$103.86 M(+3.8%) | -$103.86 M(+0.7%) |
| Jan 2020 | - | -$103.11 M(+0.9%) |
| Oct 2019 | - | -$102.23 M(+1.1%) |
| July 2019 | - | -$101.17 M(+1.1%) |
| Apr 2019 | -$100.03 M(+4.2%) | -$100.03 M(+1.2%) |
| Jan 2019 | - | -$98.89 M(+0.7%) |
| Oct 2018 | - | -$98.22 M(+1.1%) |
| July 2018 | - | -$97.18 M(+1.3%) |
| Apr 2018 | -$95.96 M(+7.7%) | -$95.96 M(+1.4%) |
| Jan 2018 | - | -$94.67 M(+2.2%) |
| Oct 2017 | - | -$92.64 M(+2.0%) |
| July 2017 | - | -$90.82 M(+1.9%) |
| Apr 2017 | -$89.14 M(+5.2%) | -$89.14 M(+1.3%) |
| Jan 2017 | - | -$87.98 M(+1.5%) |
| Oct 2016 | - | -$86.70 M(+1.1%) |
| July 2016 | - | -$85.72 M(+1.2%) |
| Apr 2016 | -$84.69 M(+7.7%) | -$84.69 M(+1.3%) |
| Jan 2016 | - | -$83.57 M(+2.9%) |
| Oct 2015 | - | -$81.20 M(+1.4%) |
| July 2015 | - | -$80.10 M(+1.9%) |
| Apr 2015 | -$78.63 M(+14.5%) | -$78.63 M(+2.0%) |
| Jan 2015 | - | -$77.07 M(+1.9%) |
| Oct 2014 | - | -$75.61 M(+7.6%) |
| July 2014 | - | -$70.28 M(+2.3%) |
| Apr 2014 | -$68.70 M | -$68.70 M(+31.5%) |
| Jan 2014 | - | -$52.23 M(+0.9%) |
| Oct 2013 | - | -$51.77 M(+12.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| July 2013 | - | -$46.11 M(+11.3%) |
| Apr 2013 | -$41.45 M(+4.0%) | -$41.45 M(+0.8%) |
| Jan 2013 | - | -$41.12 M(+0.9%) |
| Oct 2012 | - | -$40.74 M(+0.9%) |
| July 2012 | - | -$40.36 M(+1.3%) |
| Apr 2012 | -$39.85 M(+5.0%) | -$39.85 M(+1.3%) |
| Jan 2012 | - | -$39.34 M(+0.7%) |
| Oct 2011 | - | -$39.07 M(+1.1%) |
| July 2011 | - | -$38.63 M(+1.8%) |
| Apr 2011 | -$37.95 M(+3.8%) | -$37.95 M(+3.0%) |
| Jan 2011 | - | -$36.86 M(+0.3%) |
| Oct 2010 | - | -$36.73 M(+0.1%) |
| July 2010 | - | -$36.69 M(+0.4%) |
| Apr 2010 | -$36.55 M(+19.7%) | -$36.55 M(+11.5%) |
| Jan 2010 | - | -$32.78 M(+6.5%) |
| Oct 2009 | - | -$30.79 M(+1.6%) |
| July 2009 | - | -$30.31 M(-0.8%) |
| Apr 2009 | -$30.54 M(+30.2%) | -$30.54 M(+20.8%) |
| Jan 2009 | - | -$25.28 M(+3.6%) |
| Oct 2008 | - | -$24.41 M(+1.9%) |
| July 2008 | - | -$23.95 M(+2.1%) |
| Apr 2008 | -$23.45 M(+19.3%) | -$23.45 M(+4.8%) |
| Jan 2008 | - | -$22.38 M(+4.4%) |
| Oct 2007 | - | -$21.44 M(+4.3%) |
| July 2007 | - | -$20.56 M(+4.6%) |
| Apr 2007 | -$19.66 M(+22.5%) | -$19.66 M(+3.8%) |
| Jan 2007 | - | -$18.94 M(+4.2%) |
| Oct 2006 | - | -$18.17 M(+3.6%) |
| July 2006 | - | -$17.54 M(+9.3%) |
| Apr 2006 | -$16.04 M(+141.0%) | -$16.04 M(+50.1%) |
| Jan 2006 | - | -$10.69 M(+7.3%) |
| Oct 2005 | - | -$9.96 M(+23.7%) |
| July 2005 | - | -$8.05 M(+20.9%) |
| Apr 2005 | -$6.66 M(+180.9%) | -$6.66 M(+52.0%) |
| Jan 2005 | - | -$4.38 M(+11.0%) |
| Oct 2004 | - | -$3.95 M(+45.0%) |
| July 2004 | - | -$2.72 M(+14.8%) |
| Apr 2004 | -$2.37 M(+267.2%) | -$2.37 M(+234.3%) |
| Jan 2004 | - | -$709.10 K(+5.3%) |
| Oct 2003 | - | -$673.20 K(+2.2%) |
| July 2003 | - | -$658.50 K(+2.0%) |
| Apr 2003 | -$645.60 K(+5.2%) | -$645.60 K(+0.4%) |
| Jan 2003 | - | -$643.30 K |
| Apr 2002 | -$613.50 K | - |
FAQ
- What is PharmaCyte Biotech annual retained earnings?
- What is the all time high annual retained earnings for PharmaCyte Biotech?
- What is PharmaCyte Biotech annual retained earnings year-on-year change?
- What is PharmaCyte Biotech quarterly retained earnings?
- What is the all time high quarterly retained earnings for PharmaCyte Biotech?
- What is PharmaCyte Biotech quarterly retained earnings year-on-year change?
What is PharmaCyte Biotech annual retained earnings?
The current annual retained earnings of PMCB is -$115.63 M
What is the all time high annual retained earnings for PharmaCyte Biotech?
PharmaCyte Biotech all-time high annual retained earnings is -$613.50 K
What is PharmaCyte Biotech annual retained earnings year-on-year change?
Over the past year, PMCB annual retained earnings has changed by +$333.80 K (+0.29%)
What is PharmaCyte Biotech quarterly retained earnings?
The current quarterly retained earnings of PMCB is -$92.20 M
What is the all time high quarterly retained earnings for PharmaCyte Biotech?
PharmaCyte Biotech all-time high quarterly retained earnings is -$643.30 K
What is PharmaCyte Biotech quarterly retained earnings year-on-year change?
Over the past year, PMCB quarterly retained earnings has changed by +$24.15 M (+20.75%)